<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05085067</url>
  </required_header>
  <id_info>
    <org_study_id>FXHV1.0-2020-11-15</org_study_id>
    <nct_id>NCT05085067</nct_id>
  </id_info>
  <brief_title>The Efficacy of Auto-cross Linked Hyaluronic Acid Gel in the Prevention of Adhesion Reformation After Hysteroscopic Resection of Retained Products of Conception</brief_title>
  <official_title>The Efficacy of Auto-crosslinked Hyaluronic Acid Gel in the Prevention of Adhesion Reformation After Hysteroscopic Resection of Retained Products of Conception:a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fu Xing Hospital, Capital Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fu Xing Hospital, Capital Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retained product of conception (RPOC) is defined by abnormal trophoblastic persistence or&#xD;
      retained placenta inside the uterus cavity after a pregnancy independently of the outcome.&#xD;
      Untreated RPOC can compromise future fertility. RPOC are generally treated surgically, either&#xD;
      by repeated evacuation or by hysteroscopy, which exposes the uterus to additional potential&#xD;
      trauma.The combination of trauma to the gravid uterine cavity, hypoestrogenic state at the&#xD;
      time of the operation or immediately afterward and local infection is considered to be the&#xD;
      pathogenic mechanism of intrauterine adhesions (IUA) , manifested clinically by menstrual&#xD;
      abnormalities, infertility and recurrent pregnancy loss.To investigate the efficacy of&#xD;
      auto-cross linked hyaluronic acid gel in the prevention of adhesion reformation after&#xD;
      hysteroscopic resection of retained products of conception.&#xD;
&#xD;
      After the completion of hysteroscopic resection of retained products of conception, patients&#xD;
      will be randomized to one of the two groups by computer-generated numbers: [1] infusing&#xD;
      auto-cross linked hyaluronic acid gel into intrauterine cavity in the experimental group; [2]&#xD;
      no auto-cross linked hyaluronic acid gel into intrauterine cavity in the control group.&#xD;
      Second and third look outpatient hysteroscopy will be performed 4 and 8 weeks after the&#xD;
      initial surgery. The patients will be followed up about menstrual pattern at 3 months after&#xD;
      the surgery.The patients will be followed up about pregancy outcome at 12 months after the&#xD;
      surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2022</start_date>
  <completion_date type="Anticipated">January 21, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adhesion reformation rate at third-look hysteroscopy</measure>
    <time_frame>A third-look hysteroscopy will be carried out 8 weeks after the initial operation.Findings are graded according to the American Fertility Society classification.</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Adhesion score at third-look hysteroscopy</measure>
    <time_frame>A third-look hysteroscopy will be carried out 8 weeks after the initial operation.Findings are graded according to the American Fertility Society classification.</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Concentration of the menstrual pattern</measure>
    <time_frame>at 3 months after the initial surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Pregnancy rate</measure>
    <time_frame>at 12-month after the initial surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of complications</measure>
    <time_frame>up to 12 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">86</enrollment>
  <condition>Retained Products of Conception</condition>
  <arm_group>
    <arm_group_label>Group A: no auto-cross linked hyaluronic acid gel</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>no auto-cross linked hyaluronic acid gel into intrauterine cavity after hysteroscopic treatment because of retained products of conception</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B: infusing auto-cross linked hyaluronic acid gel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>infusing auto-cross linked hyaluronic acid gel into intrauterine cavity after hysteroscopic treatment because of retained products of conception</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>auto-crossed-linked hyaluronic acid gel</intervention_name>
    <description>infusing auto-cross linked hyaluronic acid gel into intrauterine cavity after hysteroscopic treatment because of retained products of conception</description>
    <arm_group_label>Group B: infusing auto-cross linked hyaluronic acid gel</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinical diagnosis of retained products of conception&#xD;
&#xD;
          -  Written consent obtained&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with severe complications of medicine and surgery&#xD;
&#xD;
          -  Acute or chronic genital tract inflammation&#xD;
&#xD;
          -  No understanding or approving the randomized controlled trial&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 8, 2021</study_first_submitted>
  <study_first_submitted_qc>October 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 20, 2021</study_first_posted>
  <last_update_submitted>October 9, 2021</last_update_submitted>
  <last_update_submitted_qc>October 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fu Xing Hospital, Capital Medical University</investigator_affiliation>
    <investigator_full_name>Yang Xue</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <keyword>Retained Products of Conception</keyword>
  <keyword>Hysteroscopy</keyword>
  <keyword>Intrauterine adhesion</keyword>
  <keyword>Auto-crossed-linked hyaluronic acid gel</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tissue Adhesions</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

